| Product Code: ETC9633833 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan mRNA Vaccine and Therapeutics Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan mRNA Vaccine and Therapeutics Market - Industry Life Cycle |
3.4 Taiwan mRNA Vaccine and Therapeutics Market - Porter's Five Forces |
3.5 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Taiwan mRNA Vaccine and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government support and funding for mRNA vaccine research and development |
4.2.2 Growing prevalence of infectious diseases and chronic conditions driving the demand for mRNA therapeutics |
4.2.3 Technological advancements in mRNA technology leading to improved efficacy and safety of vaccines and therapeutics |
4.3 Market Restraints |
4.3.1 High costs associated with mRNA vaccine and therapeutics development and production |
4.3.2 Regulatory challenges and uncertainties surrounding mRNA-based products |
4.3.3 Limited public awareness and acceptance of mRNA technology compared to traditional vaccines and therapeutics |
5 Taiwan mRNA Vaccine and Therapeutics Market Trends |
6 Taiwan mRNA Vaccine and Therapeutics Market, By Types |
6.1 Taiwan mRNA Vaccine and Therapeutics Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Self-amplifying mRNA-based Vaccines, 2021- 2031F |
6.1.4 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Conventional Non-amplifying mRNA-based Vaccines, 2021- 2031F |
6.2 Taiwan mRNA Vaccine and Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.3 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.4 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.2.5 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Taiwan mRNA Vaccine and Therapeutics Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Monoclonal Antibody, 2021- 2031F |
6.3.3 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.3.4 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3.5 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Taiwan mRNA Vaccine and Therapeutics Market, By End user |
6.4.1 Overview and Analysis |
6.4.2 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Research Laboratories and Organizations, 2021- 2031F |
6.4.3 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.5 Taiwan mRNA Vaccine and Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Taiwan mRNA Vaccine and Therapeutics Market Import-Export Trade Statistics |
7.1 Taiwan mRNA Vaccine and Therapeutics Market Export to Major Countries |
7.2 Taiwan mRNA Vaccine and Therapeutics Market Imports from Major Countries |
8 Taiwan mRNA Vaccine and Therapeutics Market Key Performance Indicators |
8.1 Research and development investments in mRNA technology |
8.2 Number of clinical trials for mRNA vaccines and therapeutics in Taiwan |
8.3 Adoption rate of mRNA vaccines and therapeutics by healthcare providers and patients |
9 Taiwan mRNA Vaccine and Therapeutics Market - Opportunity Assessment |
9.1 Taiwan mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Taiwan mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Taiwan mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 Taiwan mRNA Vaccine and Therapeutics Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Taiwan mRNA Vaccine and Therapeutics Market - Competitive Landscape |
10.1 Taiwan mRNA Vaccine and Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Taiwan mRNA Vaccine and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here